Hospital Acquired Infection Control Market to grow further up to USD 26.8 billion by 2031, at a CAGR of 3.5% during the forecast period

New York, The Global Hospital Acquired Infection Control Market was valued at USD 19.0 billion in 2021 and it is anticipated to grow further up to USD 26.8 billion by 2031, at a CAGR of 3.5% during the forecast period.

Global Hospital Acquired Infection Control Market report from Global Insight Services is the single authoritative source of intelligence on Hospital Acquired Infection Control Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Hospital Acquired Infection Control Market here: https://www.globalinsightservices.com/reports/hospital-acquired-infection-control-market/

Nosocomially acquired illnesses that are not present or incubating at the time of admission to a hospital are known as hospital-acquired infections (HAIs). These infections include bloodstream infections linked to central lines, urinary tract infections linked to catheters, surgical site infections, pneumonia linked to ventilators, pneumonia acquired in hospitals, and infections with Clostridium difficile. A productive cough, shortness of breath, abdominal discomfort, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness are signs that an infection is present.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10297/

Market Trends and Drivers
Some of the major factors driving this market are rising awareness about Hospital Acquired Infections (HAIs), the need to prevent cross-infections, the incidence of infectious diseases in healthcare facilities, and supportive government programs to encourage infection control techniques. The development of national, regional, and hospital-level infection prevention guidelines and policies as well as the expanding use of monitoring tools are both contributing to the expansion. Similarly, the market for hospital-acquired infection control is anticipated to grow as a result of factors including the increased demand for sterilization and disinfection in hospitals and clinics, technological developments in sterilization and disinfection equipment, an increase in hospitals outsourcing sterilization services to pharmaceutical and medical device companies, and an increase in the production of medical nonwovens and single-use products due to an increase in COVID-19 cases.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10297/

Global Hospital Acquired Infection Control Market Segmental Overview
The report analyses the global hospital acquired infection control market based on product & services, infection type, end user, and region.

Global Hospital Acquired Infection Control Market by Product & Services

Based on the product & services, it is segmented into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. The protective barrier segment is anticipated to dominate the market during the forecast period. This is attributed to an increase in the general public's awareness of personal hygiene, an increase in surgical procedures, a rise in the use of medical nonwovens, such as face masks, surgical drapes, and gowns, as a result of an increase in COVID-19 cases, and an increase in the manufacturing of gloves and nonwoven products.

Global Hospital Acquired Infection Control Market by Infection Type

Based on the infection type, it is segmented into hospital-acquired pneumonia, bloodstream infections, surgical site infection, gastrointestinal infections, urinary tract infections, and others. The hospital-acquired pneumonia segment is expected to dominate the market during the forecast period. Some of the major factors driving this market include rising awareness regarding Hospital Acquired Infections (HAIs), the requirement to prevent cross-infections, the prevalence of infectious diseases in healthcare facilities, and encouraging government initiatives to promote infection control practices.

Global Hospital Acquired Infection Control Market by End User

Based on the end user, it is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market. Due to an increase in the number of surgical procedures performed in hospitals, an increase in the prevalence of hospital-acquired infections, an increase in the number of hospitals and clinics, and an increase in the number of elderly people, who also have an increase in the prevalence of chronic illnesses.

Geographical Analysis of the Global Hospital Acquired Infection Control Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market and accounted for the largest revenue share in 2021. The presence of important companies, the initiatives they launched in the public and private sectors, and the rising awareness of HAIs in this area are all factors that contribute to the big share. For instance, the American-based Ecolab purchased the Swiss company vanBaerle Hygiene AG in December 2020. This expanded the product portfolio and service capabilities of Ecolab by providing a broad spectrum of cleaning, disinfection, and hygiene solutions. The CDC is in charge of epidemic investigations, surveillance, research, and HAI prevention in the United States. In accordance with the HHS Action Plan to Avoid Healthcare-Associated Infections in Acute Care Hospitals, the CDC also develops novel methods to prevent infections related to healthcare. In the upcoming years, it is anticipated that supportive measures like these will fuel regional growth.

Major Players of the Global Hospital Acquired Infection Control Market
The key players analyzed in the market are Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, and Bayer AG among others.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10297/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.